$35.37 0.54 (+1.55%)
11/6/2009 4:01 PM

Watson Pharmaceuticals, Inc. (WPI)

CAPS Rating: 3 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Current Price $35.37 Mkt Cap $3.74B
Open $34.75 P/E Ratio 13.04
Prev. Close $34.83 Div. (Yield) N/A (N/A)
Daily Range $34.42 - $35.49 Volume 1,121,644
52-Wk Range $20.19 - $38.48 Avg. Daily Vol. 1,175,000

WPI News and Commentary

Caps

How do you think WPI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

147 Outperform
16 Underperform
 

All-Star Members

43 Outperform
4 Underperform
 

Wall Street

9 Outperform
2 Underperform
 

Top WPI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

stockblog (91.26)
Submitted September 29, 2008

The generic drug industry is rapidly consolidating amidst a flurry of recent M&A activity -- including the following buyout offers:

Industry leader Teva Pharma (TEVA): buyout bids for Barr (BRL) ($7.5B) & Bentley Pharma (BNT)… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

WPI VS S&P 500 (SPY)

Fools bullish on WPI are also bullish on:

Fools bearish on WPI are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about WPI.

Recs

0
Member Avatar JDKeene (93.22) Submitted: 8/12/2009 1:01:32 PM : Outperform Start Price: $34.88 WPI Score: -5.15

Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar F111Driver (89.19) Submitted: 8/5/2009 7:52:31 AM : Outperform Start Price: $34.84 WPI Score: -8.90

WPI has a portfolio of drugs of which more than 80% are generic...with health care reform (i.e. cost cutting) looming, they are well positioned to reap the benefits. The company just launched a generic alternative to Ferrlecit (an iron therapy replacement for dialysis patients) which will spoil profits for companies selling high priced brand names (see my AMAG pick). With Paul Bisaro (former CEO of Barr Pharmaceuticals) at the helm, this company is a good bet to outperform its peers.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Doctomme (33.08) Submitted: 7/14/2009 2:28:49 AM : Outperform Start Price: $32.97 WPI Score: -8.39

Manufactor of Norco a popular alternative to Vicodin used by many hospitals, following FDA's fear of acetaminophen. (Note, most Tylenol type Overdoses are intentional)

Report this Post 0 Comments | Reply | Permalink
View All 20 Pitches »

Leaderboard

Find the members with the highest scoring picks in WPI.

Score Leader

rustat82

rustat82 (42.56) Score: +61.55

The Score Leader is the member with the highest score across all their picks in WPI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
rustat82 42.56 11/22/2006 Outperform 1Y $24.86 +42.28% -19.27% +61.55
FishOffshoreFool 67.46 11/27/2006 Outperform 5Y $25.01 +41.42% -18.90% +60.32
Sempre57 91.62 11/22/2006 Outperform 3W $25.11 +40.88% -19.30% +60.18
blazin1 68.71 11/21/2006 Outperform 3M $25.14 +40.69% -19.12% +59.82
snoopaloop < 20 11/20/2006 Outperform 5Y $25.17 +40.52% -18.92% +59.45
trustee74 97.25 12/8/2006 Outperform 3Y $25.45 +38.98% -19.28% +58.26
NetscribePhrmtcl 96.16 1/17/2007 Outperform 1Y $25.80 +37.09% -20.40% +57.50 2 Comments
IBSpud 70.52 1/12/2007 Outperform 3Y $25.97 +36.20% -20.26% +56.46
JockDasher 75.31 1/12/2007 Outperform 1Y $26.02 +35.93% -19.99% +55.92
DrunkenScotsman < 20 2/4/2008 Outperform 5Y $26.02 +35.93% -19.80% +55.73
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRBCCapMkts 81.74 4/23/2009 Outperform NS $29.29 +20.76% +27.78% -7.03
TrackStanfordRes 80.42 1/22/2009 Outperform NS $24.33 +45.38% +32.28% +13.09
TrackCreditSuiss 91.16 11/6/2008 Underperform NS $24.40 +44.96% +16.32% -28.64
TrackWachovia 35.10 9/22/2008 Outperform NS $28.98 +22.05% -11.78% +33.83
TrackJimCramer < 20 9/4/2008 Underperform 3W $30.26 +16.89% -10.87% -27.76
TrackJimCramer < 20 7/21/2008 Outperform 3W $29.30 +3.28% -1.60% +4.88 9/4/2008 @ $30.26
TrackSoros 65.62 3/31/2008 Outperform NS $29.32 +20.63% -15.82% +36.45 1 Comment
TrackWRHambrecht 59.03 2/19/2008 Outperform NS $28.52 +24.02% -18.32% +42.34
TrackEdwardOwens 98.26 9/30/2007 Outperform NS $32.40 +9.17% -26.44% +35.60 2 Comments
TrackRothCapital 75.81 9/28/2007 Outperform NS $33.00 +7.18% -26.57% +33.75
TrackUBS 86.41 5/2/2007 Outperform NS $30.01 +17.86% -23.94% +41.80
TrackRothCapital 75.81 11/8/2006 Outperform NS $25.45 +5.11% +2.15% +2.96 2/28/2007 @ $26.75
TrackJimCramer < 20 10/27/2006 Underperform 3W $26.67 +9.86% -8.30% -18.16 7/22/2008 @ $29.30
TrackFTNEquityCa 25.15 10/17/2006 Outperform NS $26.56 +33.17% -16.60% +49.77

Featured Broker Partners